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Stroke is one of the leading causes of death and morbidity worldwide. The occurrence of stroke is 
strongly dependent on well-known vascular risk factors. After rapid modernization, urbanization, and 
mechanization, East Asian countries have experienced growth in their aged populations, as well as 
changes in lifestyle and diet. This phenomenon has increased the prevalence of vascular risk factors 
among Asian populations, which are susceptible to developing cardiovascular risk factors. However, 
differing patterns of stroke risk factor profiles have been noted in East Asian countries over the past 
decades. Even though the prevalence of vascular risk factors has changed, hypertension is still prev-
alent and the burden of diabetes and hypercholesterolemia will continue to increase. Asia remains a 
high tobacco-consuming area. Although indicators of awareness and management of vascular risk 
factors have increased in many East Asian countries, their rates still remain low. Here we review the 
burdens of traditional risk factors, such as hypertension, diabetes, hypercholesterolemia, and smok-
ing in East Asia. We will also discuss the different associations between these vascular risk factors 
and stroke in Asian and non-Asian populations. 
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Introduction
Cerebrovascular disease is one of the leading causes of death 
and morbidity worldwide.1 The World Health Organization (WHO) 
estimates that there were 6.7 million stroke-related deaths in 
2012. This comprised 11.9% of all deaths which was the second 
highest cause of death worldwide.2 While age-standardized 
stroke mortality has decreased over the past two decades, par-
ticularly in high-income countries, the burden of stroke remains 
high worldwide. Indeed, the absolute number of stroke and 
stroke-related disability-adjusted life years (DALYs) loss has in-
creased.3,4
The burden of cerebrovascular disease in Asia is high. Distinct 
features, such as a higher burden of stroke than coronary heart 
disease, as well as a higher incidence of hemorrhagic stroke, 
have been noted in this region.5 In 2002, 60% of the world’s to-
tal mortality due to stroke occurred in East Asia.6 In addition, 
Asia has a higher burden of vascular risk factors overall. Previ-
ously, high-carbohydrate diets with high salt and low fat, eco-
nomic status, and underlying genetic factors were shown to be 
possible determinants for the epidemic of vascular risk factors in 
Asian countries.5,7-11 Following rapid modernization, urbanization, 
and mechanization, East Asian countries have experienced 
growth in their aged populations, as well as changes in lifestyle 
and diet. Together, these changes have exacerbated vascular risk 
factor profiles in Asian populations.12-15 As a result, the preva-
lence of vascular risk factors and their impact on cardiovascular 
disease has changed along with the varying patterns seen in 
each country.5,16
The objective of this article was to review the burden of tradi-
tional vascular risk factors and changes in these burdens over 
several decades in Asian countries. Because there is considerable 
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heterogeneity in ethnicity, as well as epidemiologic differences in 
Asia,17 we mainly focused on data from five East Asian countries: 
China, Japan, the Republic of Korea, Mongolia, and Taiwan. We 
concentrated our efforts on four risk factors carrying a high pop-
ulation attributable risk for stroke or stroke-related DALYs. These 
risk factors were hypertension, diabetes, hypercholesterolemia, 
and smoking (Tables 1 and 2). These factors are also recognized 
as major culprits of atherosclerotic stroke in the Asia Pacific Co-
hort Studies Collaboration (APCSC), a collaborative project that 
pooled data regarding cardiovascular disease in the Asia Pacific 
region from 44 existing longitudinal cohort studies. In addition 
to data from nationwide studies in each country, we also investi-
gated trends in the burden of risk factors using the published 
data on estimated trends between 1990 and 2008. These data 
included mean systolic blood pressure,18 fasting blood glucose,19 
serum total cholesterol,20 and prevalence of daily smoking.21 All Table 1. Population-attributable risks of ischemic stroke88
Risk factors Population-attributable risk
Hypertension
   Age (year) Men Women
      20–34 99 98
      35–44 99 106
      45–54 100 103
      55–64 100 102
      65–74 100 101
      75+ 100 101
Diabetes 27-5
High total cholesterol 9.1 (5.7-13.8)
Cigarette smoking 14-12*
*This value is for stroke deaths, not ischemic stroke incidence.
Table 2. Population-attributable fractions of stroke-related disability-
adjusted life-years72
Country
High systolic 
blood 
pressure
High fasting 
plasma 
glucose
High total 
cholesterol
Smoking
China 72.9 11.7 2.3 25
Japan 51.5 9.2 3.8 17.3
Mongolia 76.2 14 2.3 29.2
Republic of Korea 53.4 10.2 4.6 20.2
Taiwan 58.8 10.3 4.1 21.3
United Kingdom 47.7 9.4 5.4 14.7
United States 47.8 14.2 7.1 16.4
Table 3. Data sources and standardization methods used in previous studies estimating the trends of risk factors 
Data Data sources used for estimation Standardization method
Mean systolic blood pressure18 Data from published and unpublished health examination surveys and epidemiological 
   studies (786 country-years and 5.4 million participants)
Age-standardized to the WHO 
   reference population.
Mean fasting plasma glucose19 Data from published and unpublished health examination surveys and epidemiological 
   studies (370 country-years and 2.7 million participants)
Mean serum total cholesterol20 Data from published and unpublished health examination surveys and epidemiological 
   studies (321 country-years and 3.0 million participants)
Smoking prevalence21 Data from major multicountry survey programs, national multiyear survey programs, 
    and 3 large databases (the WHO Global Infobase, the International Smoking Statis-
tics, and the Global Health Data Exchange) (2,102 country-years of data for a total 
of 38,315 country-year-age-sex data points from 181 countries)
Stroke incidence4,65 Data from the Global Burden of Diseases, Injuries, and Risk Factors study 2010
WHO, World Health Organization.
Table 4. Commonly used definitions for traditional vascular risk factors 
Risk factors Definition
Hypertension Systolic blood pressure ≥140 mmhg
and/or diastolic blood pressure ≥90 mmhg
or use of anti-hypertensive medication
Diabetes mellitus Fasting glucose level ≥7 mmol/L (126 mg/dL) 
or A1c ≥6.5% 
or 2-hour plasma glucose in one 75-g oral glucose tolerance test ≥11.1 mmol/L (200 mg/dL) 
or random plasma glucose ≥11.1 mmol/L (200 mg/dL)
Hypercholesterolemia Fasting total cholesterol ≥6.2 mmol/L (240 mg/dL) 
or taking cholesterol lowering medication
or serum high-density lipoprotein-cholesterol <1 mmol/L (40 mg/dL)
or serum triglyceride ≥2.3 mmol/L (200 mg/dL)  
or serum low-density lipoprotein-cholesterol ≥4.1 mmol/L (160 mg/dL)
Current smoker Currently smokes either every day or some days (±  within 1, or 3, or 6 months)
or smoked greater than 100 cigarettes in a lifetime and now smokes every day or some days
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these estimated data were systematically standardized and vali-
dated, which enabled us to compare the burden of risk factors 
across countries (Table 3). 
There are diagnostic criteria for these risk factors that have 
been used in other clinical reports (Table 4). In this study, the 
definitions of risk factors were as follows: hypertension was de-
fined as having a systolic blood pressure of ≥140 mmHg, and/or 
a diastolic blood pressure of ≥90 mmHg, and/or use of antihy-
pertensive agents; diabetes was defined as having a fasting glu-
cose level of ≥7 mmol/L (126 mg/dL) or taking hypoglycemic 
agents; hypercholesterolemia was defined as having a total cho-
lesterol level of ≥6.2 mmol/L (240 mg/dL). However, because 
there are wide variations in the definition of hypercholesterol-
emia between studies, we mainly used total cholesterol levels for 
this review. 
Burdens of traditional risk factors for 
stroke in East Asia
Elevated blood pressure and prevalence of 
hypertension
Previously, populations in many East Asian countries, except 
Japan, were reported to have a lower prevalence of hypertension 
or mean systolic blood pressure lower than or similar to that of 
Western countries.22-24 Analyses of reports published between 
1980 and the early 2000s indicated that the age-standardized 
prevalence of hypertension ranged between 19% and 28% in 
East Asian countries (China, the Republic of Korea, and Taiwan), 
while Japan had a higher prevalence of hypertension (38.3%).22,24 
The age-standardized average systolic blood pressure in the 
Western Pacific region, which included China, the Republic of 
Korea, and Taiwan, had the lowest average (124 mmHg) among 
the 14 world regions defined by the WHO.23 
However, the prevalence of hypertension has notably changed 
in different manners among East Asian countries. In Japan, there 
has been a decrease in mean systolic blood pressure in all age 
groups, as well as in both men and women since around 
1965.25,26 Likewise, the prevalence of hypertension decreased in 
almost all age groups, except men aged >50 years.26 In the Re-
public of Korea, a national survey indicated that the age-adjusted 
prevalence of hypertension decreased from 29.9% in 1998 to 
25.5% in 2014, although the prevalence fluctuated to some ex-
tent, with a slight increase to 29.0% between 2007 and 2012.27 
In Taiwan, nationwide surveys such as the Nutrition and Health 
Survey in Taiwan (NAHSIT), which was carried out between 1993 
and 1996, and the Taiwanese Survey on Hypertension, Hypergly-
cemia, and Hyperlipidemia (TwSHHH), which was carried out in 
2002, revealed that the age-standardized prevalence of hyper-
tension decreased from 26.8% in NAHSIT (1993–1996) to 23.5% 
in TwSHHH (2002).28 Unlike Japan, the Republic of Korea, and 
Taiwan, China seemed to experience a rise in the prevalence of 
hypertension. In China, the age-standardized prevalence of hy-
pertension was 11.3% in 1991, 18.0% in 2002, and 26.6% in 
2007-2008.29-31 In Mongolia, two nationwide cross-sectional sur-
veys conducted by STEPS (STEPwise Approach to Surveillance) 
indicated that the prevalence of hypertension was similar in 
2005 (28.1%) and 2009 (27.3%).32,33 Figure 1 shows that the 
mean systolic blood pressure has increased since 1990 in China 
and Mongolia, while there was a decreasing trend for systolic 
blood pressure in other countries.
Within the East Asian population, blood pressure and the 
prevalence of hypertension has been reported to be higher in 
older aged men, those with high salt consumption, and popula-
tions in urbanized and medium-sized cities.5-7,24,31,34-38
Figure 1. Trends in age-standardized mean systolic blood pressure (mmHg) for men (A) and women (B).
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Diabetes
Globally, the number of diabetic adults has more than doubled 
over the last 30 years.19 In Asia, the pattern of increasing diabe-
tes prevalence has been different from that found in other re-
gions in that the increase has occurred over a much shorter time 
period. For example, the prevalence of diabetes in the United 
States has doubled over the past 40 years,39 while the prevalence 
of diabetes in many Asian countries has increased 3–5-fold dur-
ing the past 30 years.13 In China, the prevalence of diabetes has 
increased rapidly from 1% in 1980 to 9.7% in 2007–2008, and 
to 11.6% (including cases with HbA1c ≥6.5) in 2010.40,41 Japan 
and the Republic of Korea have also experienced marked in-
creases in the prevalence of diabetes.15,19,37 Likewise, the preva-
lence of diabetes has increased in Taiwan (3.15% in 2000 to 
4.22% in 2008)42 and in Mongolia (2.9% in 1999 to 6.5% in 
2009).32,43 
Global estimates of diabetes prevalence for 2013, provided by 
the International Diabetes Federation, showed that the preva-
lence of diabetes in East Asian countries (5.1% in Japan, 9.0% in 
China, 7.5% in the Republic of Korea, 8.3% in Taiwan) was simi-
lar to that in the United States (9.2%) and Canada (7.9%), and 
higher than that in the United Kingdom (4.9%). In fact, more 
than 40% of diabetic patients globally live in East Asia.44 Mean 
fasting glucose has increased in China, Japan, and Mongolia, and 
decreased in the Republic of Korea and Taiwan between 1990 
and 2008 (Figure 2).
The prevalence of diabetes and impaired glucose tolerance is 
expected to further increase in Asia at a rapid rate.44 Because 
Asians have a greater risk of diabetes, even at earlier ages and 
lower BMI levels,12,13,15,45 rapid socioeconomic development, in-
creases in westernized diet, and changes in lifestyle can aggra-
vate this phenomenon. Diabetes in East Asia was also related to 
older age, obesity, smoking, urban living, living in economically 
developed regions, and a family history of diabetes.41,46 
Hypercholesterolemia
East Asian populations had generally lower levels of serum to-
tal cholesterol than those of Western countries.5 Available re-
ports indicate that Japan was one of the countries with the low-
est values of total cholesterol in the world. However, total cho-
lesterol levels in the Japanese population increased dramatically 
between 1958 and 1986.47 The Republic of Korea and China also 
had increased mean total cholesterol levels in the 1970s and 
1990s.48 During this period, the incidence of ischemic heart dis-
ease in this region was reported to increase along with increased 
total cholesterol levels.49-51
Although the trends for increased total cholesterol levels in 
East Asian adults and children prevail, mean age-standardized 
total cholesterol levels are still lower in most East Asian coun-
tries than in Western countries, including the United States and 
the United Kingdom.20 However, in Japan, total cholesterol levels 
in males and females have increased by 0.13–0.15 mmol/L per 
decade, which has resulted in higher total cholesterol levels than 
those in the United States and Canada. In fact, total cholesterol 
levels in the Japanese population have approached levels found 
in Western Europe.20 Figure 3 shows that there was a rise in se-
rum total cholesterol levels in Japan, China, and the Republic of 
Korea. However, decreasing trends for serum total cholesterol 
levels were noted in Mongolia and Taiwan, although previous re-
ports suggest that there is a trend for an increase in dyslipidemia 
in these two countries.52,53
These trends for increasing total cholesterol levels in many 
Figure 2. Trends in age-standardized mean fasting blood glucose (mmol/L) for men (A) and women (B).
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East Asian countries were associated with increasingly older 
populations, changes in dietary patterns, and rapid urbaniza-
tion.32,33,54 As mentioned earlier, because of the epidemic transi-
tion over the past decades in East Asia, westernized diet patterns 
of total and saturated fat consumption, foods from animal 
sources, and processed foods, together with low levels of physi-
cal activity, have become more common.20,55,56 The incidence of 
obesity has also increased over the past decades, even among 
Asian young adults and children.57-60 These changes have played 
a role in the increase in average cholesterol levels in East Asia.
Smoking
Asia is the world’s largest tobacco consuming region, with 
seven Asian countries in the top ten countries ranked as having 
the highest tobacco consumption levels. China was ranked num-
ber one with 301 million current smokers, which composed 
28.1% of adults in 2010.61 Other countries in East Asia also had 
similar rates of current smokers (the Republic of Korea [24.2% in 
2014]27 and Mongolia [27.7% in 2009]32). 
Historically, there has been an imbalance in smoking preva-
lence between men and women in East Asia. Approximately 40–
50% of men in East Asia are current smokers, which is a propor-
tion higher than those found in the United States and the United 
Kingdom.5,62 The prevalence of smoking (current or former smok-
ers) reaches 70–80% among men aged 50–59 in China, Japan, 
and the Republic of Korea.62 However, the prevalence of smoking 
in women is low. Thus, the ratios of prevalence between male 
and female smokers is about 22:1 in China,61 3:1 in Japan,37 7:1 
in the Republic of Korea,36 and 7:1 in Mongolia.32 
In China, Japan, the Republic of Korea, and Taiwan, the preva-
Figure 3. Trends in age-standardized mean total cholesterol (mmol/L) for men (A) and women (B).
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lence of current smoking in men has decreased over the past de-
cades,37,63 although it is still high. In contrast, the prevalence of 
current smoking has increased in Mongolia (Figure 4).52 More-
over, there seems to be an increase in smoking among women 
and younger aged groups in some East Asian countries, such as 
China,64 the Republic of Korea,27 and Mongolia.32,33 
Impact of vascular risk factors on 
stroke among Asian populations 
Trends of stroke incidence in East Asian countries
To compare stroke incidence between countries, we extracted 
data regarding stroke incidence in 5 countries from the Global 
Burden of Diseases, Injuries, and Risk factors study (GBD 2010) 
(Table 3).4,65 Data from the United States and the United King-
dom were also used for comparison. In 1990, age-standardized 
stroke incidences (per 100,000 person-years) in East Asian coun-
tries were 247.53–347.78, which was higher than those found in 
the United States (220.66) and the United Kingdom (141.97). 
Since 1990, stroke (either ischemic or hemorrhagic) incidence 
has increased in China, Mongolia, and Taiwan, while there was a 
decrease in stroke incidence in Japan and the Republic of Korea 
(Figure 5). In Taiwan, the increase in total stroke incidence was 
due to an increase in hemorrhagic stroke incidence. In 2010, all 
East Asian countries, except for the Republic of Korea, still had 
higher stroke incidences compared to the United States and the 
United Kingdom (Figure 5).
Relationships between risk factors and stroke 
incidence in East Asia
As shown earlier, in China and Mongolia, there was an in-
crease in stroke incidence between 1990 and 2010, along with 
an increase in mean systolic blood pressure and the prevalence 
of hypertension. In contrast, there were decreases in stroke inci-
dence in Japan and the Republic of Korea, with decreasing mean 
systolic blood pressures and a decreasing prevalence of hyper-
tension. High blood pressure had the highest effect on stroke in 
the East Asia and Pacific region, with population-attributable 
fractions of 50% of stroke mortality.37 Elevated systolic blood 
pressure had a stronger relationship with stroke (in particular, 
hemorrhagic stroke) in Asians than in non-Asian populations.66-70 
A recent meta-analysis using population-based cohort studies of 
Figure 5. Trends in age-standardized incidence rate (per 100,000 people) of total stroke (A), ischemic stroke (B), and hemorrhagic stroke (C).
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11 Western countries and 11 Asian countries (mainly China, Ja-
pan, and the Republic of Korea), also demonstrated that the risk 
of stroke associated with elevated blood pressure was greater 
among Asians than Western populations. This is indicated by the 
fact that the hazard ratio (HR) for systolic blood pressure ≥140 
mmHg and the presence of hypertension were 6.22 and 2.84, re-
spectively, in Asians, compared to 2.39 and 1.79 in Western pop-
ulations.71 The Global Burden of Disease Study 2013 indicated 
that high systolic blood pressure had the largest effect on the 
burden of stroke in East Asian countries, accounting for a popu-
lation-attributable fraction of 52–73% of stroke-related DALYs. 
This is higher than the burden reported in the United Kingdom 
(48%) and the United States (48%) (Table 2).72 Recently, the IN-
TERSTROKE study also showed that the population-attributable 
risk of stroke due to hypertension was higher in Asian popula-
tions than in those of other ethnicities or regions.73 These results 
Table 5. Awareness, treatment, and control rate (%) of risk factors over the decades
Risk factor Item China Japan Mongolia Republic of Korea Taiwan
Hypertension Awareness 44.7 in 2000-2001,38
24 in 2002,30
45 in 2007-200831
54 in 2000,89
65.7 in men and 72.7 in 
women in 2000-200190
33.5 in 2001, 
63.2 in 2010-201227
22-22.5 in men and 39-39.3 
in women in 1993-1996,28, 91
55.8 in men and 73.6 in 
women in 200228
Treatment 28.2 in 2000-2001,38
20 in 2002,30
36.2 in 2007-200831
46.1 in 2000,92 
33.2-53.5 in men and 
34.3-62 in women in 
2000,26 
16.4-61.1 in men and 
33.3-57.1 in women in 
2000-2001,90
54.4 in 2008,89
29.6 in 2009,93
43.4-64.6 in men and 
31.2-68.8 in women in 
201026
74.2 in 2006,33
38.9 in 200932
31.9 in 2001, 
57.6 in 2010-201227 
13-13.4 in men and 27.6-28 
in women in 1993-1996,28,91
44.3 in men and 59.4 in 
women in 200228
Control 8.1 in 2000-2001,38
5 in 2002,30
11.1 in 2007-200831
15.2-23.4 in men and 
21.6-27.8 in women in 
2000,26
11.9 or 41.5 in 2000,89,92
27 in 2008,89
23.7 or 24.8 in 2009,89,93
29.9-33.3 in men and 
40.5-44.1 in women in 
201026
13.3 in 200932 12.1 in 2001, 
40.5 in 2010-201227
2-2.4 in men and 5-5.1 in 
women in 1993-1996,28,91
21 in men and 28.5 in  
women in 200228
Diabetes Awareness 23.7 in 2000-2001,94
30.1 in 201082
71.3 in 2010-201227 70 in men and 63 in women 
in 1993-199695
Treatment 20.3 in 2000-2001,94
25.8 in 201082
37.4% with drugs,
13.7% with insulin 
in 2006,33 
16.7% with drugs,
9.9% with insulin in 
200932
62.3 in 2010-201227
Control 8.3 in 2000-2001,94
39.7 (among patients 
treated) in 201082
34 in 2000-2002,96
36.2-43.1 in 2006-200897
28.2 in 2010-201227 27 in 1998,98
11.2 (among patients with 
insulin therapy) in 2005-
2006,99
11.7 (among patients with 
insulin therapy) in 2010-
2012100
Hypercholeste- 
   rolemia
Awareness 24.4 in 2003-2013101 55.7 in men and 58.6 in 
women in 2000-200190
45.2 in 2010-201227
Treatment 8.8 in 2003-2013101 13.3-52.2 in men and 
16.7-52.5 in women in 
2000-2001,90
35 in 2010-201227
Control 4.3 in 2003-2013101 72.3 (44.5 for secondary 
prevention) in 2009102
28.1 in 2010-201227 64.9 in 2002-2003,103
65.9 (among patients with 
lipid lowering therapy) in 
2006-2007104
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imply that stroke or stroke burden can be effectively prevented 
by better hypertension management in Asia. In fact, improve-
ments in hypertension control were related to decreases in sys-
tolic blood pressure and the risk of stroke or stroke burden in Ja-
pan and the Republic of Korea. Although the impact of hyper-
tension on stroke has declined during the past several decades 
owing to improved management of hypertension, hypertension 
is still the strongest risk factor for stroke in East Asia.74,75
The trends for diabetes or hypercholesterolemia have not al-
ways been comparable to changes in stroke incidence in differ-
ent countries. This may be due to relatively smaller effects of di-
abetes or hypercholesterolemia compared to hypertension on the 
incidence of stroke. However, as the impact of hypertension on 
stroke occurrence decreases, the contributions of diabetes or hy-
percholesterolemia will become greater. In fact, in Japan, a rapid 
increase in the prevalence of metabolic disorders such as glucose 
intolerance, hypercholesterolemia, and obesity, has offset the 
impacts of improvements in hypertension control on stroke oc-
currence.74 Furthermore, considering that many Asian countries 
have experienced increasing burdens of atherosclerosis in intra- 
and extra-cranial cerebral arterial beds, which can be affected 
by hypercholesterolemia and metabolic syndrome,76-80 the in-
creasing trends for diabetes and hypercholesterolemia may have 
greater effects on stroke risk in the future. 
Awareness, treatment, and control 
rates of risk factors
Table 5 summarizes previous reports regarding awareness, 
treatment, and control rates of traditional risk factors for stroke. 
Although it is difficult to compare these rates directly because of 
difference in study populations and methodologies, awareness, 
treatment, and control rates of traditional risk factors for stroke 
seemed to have increased in many East Asian countries (Table 5). 
For example, rising trends for awareness rates for hypertension 
have been observed in the Republic of Korea (34% in 2001 and 
63.2% in 2010–2012),27 and Taiwan (about 23–39% in 1993–
1996 and 56–74% in 2002).28 There has also been an increase in 
the control rates for hypertension in Japan, the Republic of Ko-
rea, Taiwan, and China (Table 5). 
In Asia, the awareness and treatment rates of vascular risk 
factors are higher in older populations, women, and patients liv-
ing in urban areas.26,27,30,38,81,82 Increases in education level, pre-
ventive measures implemented by health professionals and the 
government, and campaigns and advertisements may have con-
tributed to these improvements in awareness, treatment, and 
control rate of risk factors.83 However, despite the improvements, 
these rates, particularly the control rate, still remain low. Most 
regions have lower than approximately 50% control rates. These 
rates are lower than those in Western countries. For example, in 
the United States, the awareness, treatment, and control rates of 
hypertension were 81%, 74%, and 53%, respectively.84 This im-
plies that proper public health strategies and optimal treatment 
approaches should be adopted to further reduce stroke and car-
diovascular risks. For example, innovative initiatives targeting 
children have shown some success. A meta-analysis of 58 stud-
ies evaluating interventions in children to increase stroke aware-
ness indicated a 70% improvement compared to baseline.85 
Many East Asian countries have had weak national legislation 
prohibiting passive smoking or restricting the activities of the 
tobacco industry.62 In fact, the percentage of those planning to 
stop smoking is low (<20%) among current Asian smokers. Sup-
port for the cessation of drug use is not enough. For example, 
only 5–14% of smokers use nicotine replacement drugs in East 
Asia. Considering the benefits of implementing multi-component 
quitting assistance systems on smoking cessation,62,86 more ag-
gressive multidisciplinary tobacco control policies are needed in 
many East Asian countries.
Limitations
There are some limitations in this review. First, we did not in-
clude other risk factors, such as atrial fibrillation (AF), whose in-
cidence is expected to increase in Asia.87 Second, the associa-
tions between traditional risk factors and stroke subtypes or 
stroke mechanisms were not reviewed in detail. In addition, oth-
er Asian regions, such as South and Southeast Asia, were not in-
cluded in this review. 
Conclusions
Over the past decades, Asia has experienced rapid epidemio-
logic transitions. Along with economic and nutritional changes, 
the burden of vascular risk factors and their impact on cardio-
vascular disease has changed in East Asian countries. Although 
there are some variations between countries, hypertension is still 
prevalent and a significant risk factor for stroke in many Asian 
countries. The burdens of diabetes and hypercholesterolemia will 
continue to increase. Asia also remains a high tobacco consum-
ing area. Although awareness of patients’ diagnoses and risk 
factors has improved compared to the past decades, these rates 
remain low. Treatment and control rates are even lower in East 
Asia. The incidence or burden of stroke has differentially changed 
in response to the burdens of risk factors in Asian countries. 
These imply that further efforts will be required to determine the 
exact epidemiologic statuses and to plan interventional ap-
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proaches for reducing the burdens of risk factors and stroke in 
East Asia.
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